CD4 and infection: Moreover, at least in vitro macrophage-based transmission of infection to CD4+ T cells (and vice versa) can be resistant to antiretroviral therapy and to some BNAbs, suggesting that current therapies may be insufficient or inadequate to stop cell-to-cell spread of the virus.